What is the pathophysiology of brain tumors?

Pathophysiology of Brain Tumors

Overview of Brain Tumor Pathogenesis

Brain tumors arise through distinct pathophysiologic mechanisms depending on whether they are primary tumors originating within the central nervous system or metastatic lesions spreading from distant sites.

Primary Brain Tumors (Gliomas)

Molecular and Genetic Drivers

Primary brain tumors develop through complex genetic, epigenetic, and metabolic alterations that converge to disrupt normal neural cell differentiation and proliferation. 1

• Genetic mutations drive tumorigenesis through specific pathways:

  • Primary glioblastomas develop via EGFR amplification 1
  • Secondary glioblastomas arise through IDH1/2 or TP53 mutations 1
  • Pediatric high-grade gliomas are defined by histone H3K27M mutations that impact epigenetic modifications 1

• Epigenetic deregulation serves as a unified node where genetic, metabolic, and microenvironmental factors converge 2

  • Widespread DNA methylation changes occur, with hundreds of genes subject to CpG island promoter hypermethylation in each glioblastoma 3
  • Redistribution of histone marks and disruption of chromatin structure define many brain cancers 2
  • These epigenetic alterations affect cell identity, cell state, and drive neoplastic transformation 2

Cellular Mechanisms

• Deregulated neurogenesis is central to brain tumor pathophysiology, with neurodevelopmental transcription factors, microRNAs, and epigenetic factors blocking normal neuronal and glial differentiation 4

• Tumor heterogeneity arises from multiple cell types within glioblastomas:

  • Some cells possess increased tumorigenicity and stem cell-like capacity 5
  • Brain tumor stem cells (BTSCs) may be the cells of origin for tumor relapse 5
  • Tumor cells grow and divide in an uncontrolled manner, recapitulating but dysregulating features of normal neurogenesis 1

Microenvironmental Interactions

The tumor microenvironment plays a critical role through interactions between tumor cells and parenchymal cell populations. 5

• Vascular interactions: The tumor vasculature not only nourishes glioblastomas but provides a specialized niche for stem-like cells 5

• Microglial involvement: Microglial cells can contribute up to 30% of brain tumor mass and facilitate glioblastoma cell invasion 5

• Astrocyte conversion: Non-neoplastic astrocytes are converted into a reactive phenotype by the glioma microenvironment, secreting factors that influence tumor biology 5

Metastatic Brain Tumors

The Metastatic Cascade

Cancer cells spreading to the brain must complete a multi-step process involving epigenetic changes, vascular invasion, blood-brain barrier traversal, and establishment within the brain parenchyma. 6

Step 1: Initial Spread and Vascular Entry

• Epigenetic and proliferative changes initiate the metastatic process, including growth of preexisting or development of new blood vessels (angiogenesis) 6

• Vascular invasion follows these proliferative changes, allowing cancer cells to enter the bloodstream 6

Step 2: Blood-Brain Barrier Traversal

Cancer cells reaching the brain must traverse the blood-brain barrier through upregulation of specific genes and proteins. 6

• Key molecular mechanisms include:
  • Upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinases for extracellular matrix destruction 6
  • Activation of signaling pathways that permeabilize the blood-brain barrier 6
  • Increased expression of proteins enabling proteolysis, extravasation, and tumor cell colonization 6

Step 3: Adhesion and Colonization

• Endothelial adhesion occurs through upregulation of particular cell surface proteins and growth factors, promoting tumor cell interactions with brain endothelia 6

• Tumor-brain cell interactions are critical for successful colonization 6, 7:

  • Formation of tumor-astrocyte gap junctions 6, 7
  • Secretion of inflammatory chemokines promoting tumor cell motility, invasion, and survival 6, 7

Specific Molecular Pathways in Brain Metastasis

Complex molecular interactions between metastatic cells and the brain microenvironment drive successful colonization. 6

• Breast cancer brain metastases involve:

  • Estradiol-induced activation of brain-derived neurotrophic factor in astrocytes interacting with TrkB receptors on tumor cells 6
  • COX2, EGFR ligand HBEGF, and ST6GALNAC5 facilitate metastasis development 6, 8

• Lung cancer brain metastases are associated with:

  • LEF1, Cadherin 2, and KIFC1 expression 6, 8

• Neuronal interactions: Synaptic formation between cancer cells and glutamergic neurons allows NMDA receptor activation 6

• Astrocyte-mediated proliferation: Loss of PTEN expression in cancer cells is driven by signals from resident astrocytes, leading to chemokine-mediated proliferation 6

• STAT3 pathway: Cancer cells coopt a pro-metastatic program driven by STAT3 in reactive astrocytes 6

Clinical Implications

Common Pitfalls

• Genomic heterogeneity exists between brain metastases and primary tumors, suggesting specific transformations occur that allow brain colonization 6
• This heterogeneity contributes to differing intracranial and extracranial responses to systemic therapy 6

Therapeutic Targets

• Targeting metastatic pathways offers substantial promise in inhibiting successful proliferation of brain metastases 6
• Promoting differentiation in primary brain tumors through genetic or pharmacological manipulation may reduce treatment resistance, suppress tumor growth, and prevent recurrence 4